Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
08/2002
08/14/2002EP1230241A2 Adenosine receptor antagonists and methods of making and using the same
08/14/2002EP0960167B1 Bifluorophoric perylene colourants
08/13/2002US6433165 Chemokine receptor antagonists and methods of use therefor
08/13/2002US6432976 Analgesics; side effect reduction
08/13/2002US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases
08/08/2002WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof
08/08/2002US20020107392 Quinolinone derivatives
08/08/2002CA2432997A1 Antagonists of mcp-1 function and methods of use thereof
08/07/2002EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds
08/07/2002EP0760370B1 Novel carbapenem derivatives
08/07/2002CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
08/06/2002US6429310 Photonic or electronic energy conducting
08/01/2002WO2002059123A2 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
08/01/2002WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
08/01/2002WO2001003126A9 High density non-volatile memory device
08/01/2002US20020103230 Heterocyclic compounds
08/01/2002US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine
08/01/2002US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage
08/01/2002CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
07/2002
07/31/2002EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials
07/31/2002EP1226141A1 Heterocyclic substituted pyrazolones
07/31/2002EP0735871B1 Pharmaceutical compositions containing ceftriaxone and penems
07/31/2002EP0719267B1 Second messenger cell signaling inhibitors
07/30/2002US6426350 Alpha-2 adrenoceptor antagonists; use treating nervous system disorders
07/25/2002WO2002057271A2 Thienopyrimidine-based inhibitors of the src family
07/25/2002WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/25/2002WO2002000653A3 Fused cyclic compounds as modulators of nuclear hormone receptor function
07/25/2002US20020099055 Novel compounds
07/25/2002CA2426775A1 Thienopyrimidine-based inhibitors of the src family
07/23/2002US6423840 Forming n-acylamino compound
07/18/2002WO2002055520A2 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
07/18/2002WO2002055083A1 TRIAZOLO[4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
07/18/2002WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
07/18/2002WO2002002557A3 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
07/18/2002US20020095061 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/17/2002EP1222191A2 Benzodiazepin derivatives, the production and use thereof
07/17/2002EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
07/16/2002US6420553 Metallization a porphyrin to form metalloporprin
07/16/2002US6420461 Compounds based on polyalkyl-1-oxadiazaspirodecane compounds
07/16/2002US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines
07/11/2002WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components
07/10/2002EP0690862B1 Quinolone derivatives and processes for preparing the same
07/10/2002CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof
07/04/2002WO2002014317A3 Substituted pyrazoles
07/04/2002US20020086871 Pharmaceutical composition for the treatment of CNS and other disorders
07/04/2002US20020084446 Hyperpolarizable organic chromophores
07/03/2002EP1219626A1 Compounds for fluorescence labeling
07/03/2002EP1219622A2 Pharmaceutical compositions for CNS and other disorders
07/03/2002CN1087018C Bis-pyrido [4,3-b] carbazole compounds, process for their prepn. and pharmaceutical compsns. contg. them
06/2002
06/27/2002WO2002000616A3 Novel cephalosporin compounds and process for preparing the same
06/27/2002US20020082424 Alkylating an aryl halide with 1,3-dichloropropene and n-tetrabutylammonium iodide catalyst for forming vinyl chloride compound which is subjected to cyclization using tribuytyl tin hydride, catalyst and toluene as the solvent
06/27/2002US20020081626 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample
06/26/2002EP1216250A1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
06/26/2002EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents
06/26/2002EP1216244A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d 4? antagonists
06/26/2002EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
06/26/2002CN1086706C Pyrido [3,2,1,i,j][3,1] benzoxazine derivatives
06/25/2002US6410628 Photoactivatable nitrogen-containing bases based on alpha-amino ketones
06/25/2002US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents
06/20/2002WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
06/20/2002WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
06/20/2002WO2002048109A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators
06/20/2002WO2002020013A3 A method for treating allergies using substituted pyrazoles
06/20/2002US20020077503 Used to prepare one-pot systems with base-catalysable oligomers or monomers having storage stability; catalysts
06/20/2002US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder
06/19/2002EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
06/19/2002EP1214322A2 Amino-triazolopyridine derivatives
06/19/2002EP1214060A2 Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
06/19/2002EP1196199A4 Water soluble multi-biotin-containing compounds
06/19/2002EP1150984A4 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
06/18/2002US6406525 Dioxazine compounds containing sulphonic acid groups, dye for cotton or paper, printing inks; blue shades with excellent fastnesses
06/13/2002WO2002020011A3 A method for treating allergies using substituted pyrazoles
06/13/2002WO2002014315A3 Substituted pyrazoles
06/13/2002WO2001097618A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
06/12/2002EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
06/12/2002CN1353609A Amide substituted imidazoquinolines
06/11/2002US6403809 Compounds for electronic devices
06/06/2002WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
06/06/2002WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists
06/06/2002US20020068744 Interacting with tubulin and microtubules and promoting microtubule polymerization
06/05/2002EP1210714A2 High density non-volatile memory device
06/05/2002EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
06/05/2002EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042312A1 Novel carbapenem derivatives
05/30/2002WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives
05/30/2002WO2002005953A3 Asymmetric synthetic methods based on phase transfer catalysis
05/30/2002WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
05/30/2002US20020065419 Cyclobutenedione compounds
05/30/2002CA2429675A1 Novel carbapenem derivatives
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/23/2002WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
05/23/2002WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/23/2002WO2002039953A2 Texaphyrin coordination compounds and uses thereof
05/23/2002US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides
05/23/2002US20020059684 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes
05/23/2002DE10122895A1 New lactam-substituted pyrazolo(3,4-b)pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
05/23/2002CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
05/23/2002CA2429411A1 Texaphyrin coordination compounds and uses thereof
05/23/2002CA2428335A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 111